Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3754712

Documents

Beta release

Statistics of Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study1
Statistics for this year
PeriodVisitsDownloads
202433
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0711
2024-0800
2024-0900